[go: up one dir, main page]

FI971172L - Menetelmä annosyksikköjen valmistamiseksi märkärakeistamalla - Google Patents

Menetelmä annosyksikköjen valmistamiseksi märkärakeistamalla Download PDF

Info

Publication number
FI971172L
FI971172L FI971172A FI971172A FI971172L FI 971172 L FI971172 L FI 971172L FI 971172 A FI971172 A FI 971172A FI 971172 A FI971172 A FI 971172A FI 971172 L FI971172 L FI 971172L
Authority
FI
Finland
Prior art keywords
wet granulation
dosage units
preparing dosage
preparing
granulation
Prior art date
Application number
FI971172A
Other languages
English (en)
Swedish (sv)
Other versions
FI118791B (fi
FI971172A0 (fi
Inventor
Haan Pieter De
Jocominus Antonius Ma Zwinkels
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of FI971172L publication Critical patent/FI971172L/fi
Publication of FI971172A0 publication Critical patent/FI971172A0/fi
Application granted granted Critical
Publication of FI118791B publication Critical patent/FI118791B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI971172A 1994-09-22 1997-03-20 Menetelmä annosyksikköjen valmistamiseksi märkärakeistamalla FI118791B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94202728 1994-09-22
EP94202728 1994-09-22
PCT/EP1995/003692 WO1996009056A1 (en) 1994-09-22 1995-09-19 Process of making dosage units by wet granulation
EP9503692 1995-09-19

Publications (3)

Publication Number Publication Date
FI971172L true FI971172L (fi) 1997-03-20
FI971172A0 FI971172A0 (fi) 1997-03-20
FI118791B FI118791B (fi) 2008-03-31

Family

ID=8217217

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971172A FI118791B (fi) 1994-09-22 1997-03-20 Menetelmä annosyksikköjen valmistamiseksi märkärakeistamalla

Country Status (22)

Country Link
US (1) US5916593A (fi)
EP (1) EP0782449B1 (fi)
JP (1) JP4334616B2 (fi)
KR (1) KR100384264B1 (fi)
CN (1) CN1101681C (fi)
AT (1) ATE236639T1 (fi)
AU (1) AU700645B2 (fi)
BR (1) BR9509019B1 (fi)
CA (1) CA2200754C (fi)
CZ (1) CZ289081B6 (fi)
DE (1) DE69530308T2 (fi)
DK (1) DK0782449T3 (fi)
ES (1) ES2196079T3 (fi)
FI (1) FI118791B (fi)
HU (1) HU226619B1 (fi)
MX (1) MX9702162A (fi)
NO (1) NO311492B1 (fi)
NZ (1) NZ293606A (fi)
PL (1) PL181406B1 (fi)
PT (1) PT782449E (fi)
RU (1) RU2166936C2 (fi)
WO (1) WO1996009056A1 (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
EP0955048A1 (en) * 1998-03-12 1999-11-10 Akzo Nobel N.V. Making dosage units using low shear granulation
AU2669700A (en) * 1999-02-24 2000-09-14 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna- 4,15-dien-20-yn-3-one (org 30659) and lactose
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
RS50262B2 (sr) * 1999-08-31 2018-10-31 Bayer Pharma AG Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
EP1216713A1 (en) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
US20030027848A1 (en) * 2001-06-15 2003-02-06 Anne Billotte Stabilized formulations
EP1275377B1 (en) * 2001-07-11 2003-06-18 Apr Applied Pharma Research S.A. Granulates containing liposoluble substances and process of preparation thereof
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
GB0209265D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
RU2315603C2 (ru) 2002-12-20 2008-01-27 Ф.Хоффманн-Ля Рош Аг Композиция с высокой дозой ибандроната
RU2228747C1 (ru) * 2003-03-03 2004-05-20 Открытое акционерное общество "Щелковский витаминный завод" Антиангинальное средство пролонгированного действия
CZ298224B6 (cs) * 2003-04-29 2007-07-25 Pliva Istrazivanje I Razvoj D.O.O. Farmaceutická kompozice obsahující jako úcinnou látku ribavirin a zpusob její výroby
AU2004275470B2 (en) * 2003-09-29 2010-12-02 Novo Nordisk Health Care Ag Improved stability of progestogen formulations
JP2007506796A (ja) * 2003-09-29 2007-03-22 ノボ・ノルディスク・フェムケア・アーゲー Ｈｒｔ製剤
JP4412963B2 (ja) * 2003-10-10 2010-02-10 旭有機材工業株式会社 バルブ用樹脂製部材
EP1734930A2 (en) * 2004-04-09 2006-12-27 Smithkline Beecham Corporation Low dose pharmaceutical products
US7846466B2 (en) * 2004-06-10 2010-12-07 Northwestern University Biodegradable scaffolds and uses thereof
AU2005297923B2 (en) * 2004-10-25 2010-12-23 Japan Tobacco Inc. Solid medicinal preparation improved in solubility and stability and process for producing the same
EP1855690B1 (en) * 2005-01-21 2016-06-01 Warner Chilcott Company, LLC A tetracycline metal complex in a solid dosage form
EP2281556A1 (en) * 2005-02-25 2011-02-09 F. Hoffmann-La Roche AG Tablets with improved drugs substance dispersibility
US8617597B2 (en) * 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
WO2009132208A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
MX2011001487A (es) * 2008-08-08 2011-03-30 Mcneil Ppc Inc Uso de sucralosa como agente granulante.
US8314122B2 (en) 2008-10-09 2012-11-20 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Using of organic solvents in wet granulation of moxifloxacin
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
JP2017001989A (ja) * 2015-06-11 2017-01-05 ニプロ株式会社 医薬組成物の製造方法及び医薬組成物
JP6759478B2 (ja) * 2019-02-13 2020-09-23 富士製薬工業株式会社 経口固形組成物、その製造方法、及びその製造方法によって得られた経口用錠剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969502A (en) * 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
GB2192128A (en) * 1986-07-03 1988-01-06 Fa Ez Khan Production of pharmaceutical unit dosage forms
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
AU671536B2 (en) * 1993-02-23 1996-08-29 Warner-Lambert Company A process for the preparation of substantially alcohol free pharmaceutical compositions
DE69418744T2 (de) * 1993-03-05 1999-11-11 Akzo Nobel N.V., Arnheim/Arnhem Verwendung von Pregnanderivaten zur Behandlung von Tumoren
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
BR9509019B1 (pt) 2009-01-13
DE69530308T2 (de) 2003-10-16
CZ289081B6 (cs) 2001-10-17
CN1161650A (zh) 1997-10-08
NO971361D0 (no) 1997-03-21
ES2196079T3 (es) 2003-12-16
CA2200754A1 (en) 1996-03-28
HUT77611A (hu) 1998-06-29
CA2200754C (en) 2008-04-15
BR9509019A (pt) 1997-12-30
PT782449E (pt) 2003-07-31
PL181406B1 (pl) 2001-07-31
EP0782449B1 (en) 2003-04-09
NO971361L (no) 1997-05-21
JP4334616B2 (ja) 2009-09-30
EP0782449A1 (en) 1997-07-09
AU700645B2 (en) 1999-01-14
ATE236639T1 (de) 2003-04-15
RU2166936C2 (ru) 2001-05-20
NZ293606A (en) 1998-06-26
NO311492B1 (no) 2001-12-03
KR970706001A (ko) 1997-11-03
US5916593A (en) 1999-06-29
JPH10505846A (ja) 1998-06-09
DK0782449T3 (da) 2003-08-04
DE69530308D1 (de) 2003-05-15
PL319373A1 (en) 1997-08-04
FI118791B (fi) 2008-03-31
CN1101681C (zh) 2003-02-19
WO1996009056A1 (en) 1996-03-28
HU226619B1 (en) 2009-04-28
KR100384264B1 (ko) 2003-08-30
CZ89997A3 (en) 1997-09-17
AU3608295A (en) 1996-04-09
MX9702162A (es) 1997-06-28
HK1002172A1 (en) 1998-08-07
FI971172A0 (fi) 1997-03-20

Similar Documents

Publication Publication Date Title
FI971172L (fi) Menetelmä annosyksikköjen valmistamiseksi märkärakeistamalla
FI970995L (fi) Farmaseuttisia yhdisteitä
FI971018L (fi) Farmaseuttisia yhdisteitä
DE69519507D1 (de) Produktionssystem
FI945075L (fi) Reaaliaikainen langaton telemaksujärjestelmä
FI951702A7 (fi) Farmaseuttinen menetelmä osteoporoosin hoitamiseksi
FI954243A7 (fi) Farmaseuttiset yhdisteet
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
FI20040310A7 (fi) Menetelmä bentsosykloalkyyliatsolitionijohdannaisten valmistamiseksi
FI20050181L (fi) Menetelmä valmistaa 21-kloorikortikosteroideja
NO20005027L (no) Fremgangsmåte for våt-granulering
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
FI970427A7 (fi) Menetelmä mikrobinvastaisten yhdisteiden valmistamiseksi
BR9502171A (pt) Sistema de lastro para máquina de compactação
FI964001L (fi) Menetelmä 7-trialkyylisilyylibakkatiini III:n valmistamiseksi
EP1023250A4 (en) METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE
FI962490A7 (fi) Menetelmä pesuainerakeiden valmistamiseksi
FI912868A7 (fi) Menetelmä farmaseuttisten yhdisteiden valmistamiseksi
MA24472A1 (fr) Procede
FI963018L (fi) Menetelmä gammapyronien valmistamiseksi
MA24470A1 (fr) Procede
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
FI964410L (fi) Menetelmä 4-amino-delta4-3-ketosteroidien valmistamiseksi 4-nitro-delta4-3-ketosteroidien kautta
FI964190A7 (fi) Menetelmä substituoidun 4-hydroksibentsaldehydin valmistamiseksi
FI964002A7 (fi) Menetelmä 7-hydroksitaksaanien valmistamiseksi

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON